In a bid to regain “public trust” and open up opportunities for “U.K. sovereign capabilities,” Frith said “interoperability, resilience and trusted common standards” will be “baked into” the new procurement round, though non-U.K. firms will also be encouraged to bid.
Palantir’s contract has attracted considerable scrutiny from campaigners, health professionals and MPs over controversial views expressed by the company’s founders and concerns about vendor lock-in.
Two parliamentary committees have called for its NHS contract to be ended in the last year.
“We want to give the health and care system more choice, greater resilience and less dependence on any single supplier, as well as the ability to adapt and evolve as new technologies emerge in future, with better value for taxpayers through time,” Frith said.
“These objectives require a new approach — an approach that will stimulate a more diverse and innovative supplier market, including greater use of sovereign AI as well as internationally developed capabilities,” he added.
This approach will encompass investment in strategic technologies, changing how novel technologies are procured, and developing open standards, Frith said.

